These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16732552)

  • 1. Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain.
    Dolcetta D; Perani L; Givogri MI; Galbiati F; Amadio S; Del Carro U; Finocchiaro G; Fanzani A; Marchesini S; Naldini L; Roncarolo MG; Bongarzone E
    J Gene Med; 2006 Aug; 8(8):962-71. PubMed ID: 16732552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrovirus-mediated gene transfer and galactocerebrosidase uptake into twitcher glial cells results in appropriate localization and phenotype correction.
    Luddi A; Volterrani M; Strazza M; Smorlesi A; Rafi MA; Datto J; Wenger DA; Costantino-Ceccarini E
    Neurobiol Dis; 2001 Aug; 8(4):600-10. PubMed ID: 11493025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GALC transduction leads to morphological improvement of the twitcher oligodendrocytes in vivo.
    Meng XL; Shen JS; Watabe K; Ohashi T; Eto Y
    Mol Genet Metab; 2005 Apr; 84(4):332-43. PubMed ID: 15781194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model.
    Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL
    Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2.
    Lin D; Fantz CR; Levy B; Rafi MA; Vogler C; Wenger DA; Sands MS
    Mol Ther; 2005 Sep; 12(3):422-30. PubMed ID: 15996520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined hematopoietic and lentiviral gene-transfer therapies in newborn Twitcher mice reveal contemporaneous neurodegeneration and demyelination in Krabbe disease.
    Galbiati F; Givogri MI; Cantuti L; Rosas AL; Cao H; van Breemen R; Bongarzone ER
    J Neurosci Res; 2009 Jun; 87(8):1748-59. PubMed ID: 19185028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy.
    Lattanzi A; Salvagno C; Maderna C; Benedicenti F; Morena F; Kulik W; Naldini L; Montini E; Martino S; Gritti A
    Hum Mol Genet; 2014 Jun; 23(12):3250-68. PubMed ID: 24463623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transduction of cultured oligodendrocytes from normal and twitcher mice by a retroviral vector containing human galactocerebrosidase (GALC) cDNA.
    Costantino-Ceccarini E; Luddi A; Volterrani M; Strazza M; Rafi MA; Wenger DA
    Neurochem Res; 1999 Feb; 24(2):287-93. PubMed ID: 9972877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal administration of AAV/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant.
    Karumuthil-Melethil S; Marshall MS; Heindel C; Jakubauskas B; Bongarzone ER; Gray SJ
    J Neurosci Res; 2016 Nov; 94(11):1138-51. PubMed ID: 27638599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
    Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
    Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviral vector-mediated transfer of the galactocerebrosidase (GALC) cDNA leads to overexpression and transfer of GALC activity to neighboring cells.
    Rafi MA; Fugaro J; Amini S; Luzi P; de Gala G; Victoria T; Dubell C; Shahinfar M; Wenger DA
    Biochem Mol Med; 1996 Aug; 58(2):142-50. PubMed ID: 8812733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
    Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
    Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation.
    Pellegatta S; Tunici P; Poliani PL; Dolcetta D; Cajola L; Colombelli C; Ciusani E; Di Donato S; Finocchiaro G
    Neurobiol Dis; 2006 Feb; 21(2):314-23. PubMed ID: 16199167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multipotent stromal cells alleviate inflammation, neuropathology, and symptoms associated with globoid cell leukodystrophy in the twitcher mouse.
    Scruggs BA; Zhang X; Bowles AC; Gold PA; Semon JA; Fisher-Perkins JM; Zhang S; Bonvillain RW; Myers L; Li SC; Kalueff AV; Bunnell BA
    Stem Cells; 2013 Aug; 31(8):1523-34. PubMed ID: 23606584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy.
    Meneghini V; Lattanzi A; Tiradani L; Bravo G; Morena F; Sanvito F; Calabria A; Bringas J; Fisher-Perkins JM; Dufour JP; Baker KC; Doglioni C; Montini E; Bunnell BA; Bankiewicz K; Martino S; Naldini L; Gritti A
    EMBO Mol Med; 2016 May; 8(5):489-510. PubMed ID: 27025653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD).
    Lee WC; Tsoi YK; Dickey CA; Delucia MW; Dickson DW; Eckman CB
    Neurobiol Dis; 2006 Aug; 23(2):273-80. PubMed ID: 16759875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements.
    Shen JS; Watabe K; Ohashi T; Eto Y
    Gene Ther; 2001 Jul; 8(14):1081-7. PubMed ID: 11526455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
    Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
    Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice.
    Pan X; Sands SA; Yue Y; Zhang K; LeVine SM; Duan D
    Hum Gene Ther; 2019 Sep; 30(9):1039-1051. PubMed ID: 31184217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
    Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
    J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.